Tag: Almirall
Almirall: The stock jumps after an agreement with Novo Nordisk
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Almirall: Alliance with the Belgian etherna in messenger RNA
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Almirall: The title rises, green light from the EU in eczema
(CercleFinance.com) – The Spanish pharmaceutical group Almirall recorded a sharp rise on Friday on the Madrid Stock Exchange following the announcement of the marketing authorization in Europe for its new…
Almirall: favorable opinion from the EU in eczema
(CercleFinance.com) – Experts from the European Medicines Agency (EMA) spoke out on Friday in favor of marketing authorization for Ebglyss (lebrikizumab) from Almirall. The EMA Committee for Medicinal Products for…
Almirall: advance after its quarterly, objectives maintained
(CercleFinance.com) – The Spanish biopharmaceutical group Almirall rose slightly on the stock market on Monday after maintaining its annual objectives and despite a drop in its operating profit in the…
Almirall: Results better than expected, the title climbs
(CercleFinance.com) – The Spanish pharmaceutical company Almirall took nearly 4% on the Madrid Stock Exchange on Monday after reporting better-than-expected annual results. The Barcelona-based group, which specializes in dermatology, announced…
Almirall: RBC initiates ‘outperformance’ coverage
(CercleFinance.com) – Royal Bank of Canada initiated coverage of the Almirall stock on Tuesday with an ‘outperformance’ opinion and a target price of 13.5 euros. In a research note released…
Almirall: The results struggle to support the title
(CercleFinance.com) – The Spanish pharmaceutical company Almirall reported lower results for the first half on Monday and at the same time confirmed its objectives for the full year. The Barcelona…
Almirall: The results are not convincing
(CercleFinance.com) – The Spanish biopharmaceutical laboratory Almirall fell by more than 8% on Monday on the Madrid Stock Exchange despite a “good start to the year” marked by “solid performance”…